Proposed Permanent Rules: In Promulgation Process
Relating to monitored prescription drug history reports.
Relating to excluding Fenfluramine.
Relating to scheduling Methiopropamine.
Relating to national provider identifier requirement.
Relating to scheduling Mesocarb.
Relating to excluding [18 F]FP-CIT.
Relating to scheduling Zipeprol.
Relating to scheduling Amineptine.
/code/chr/active